Concepedia

Chelsea Bentow

CB

30

Publications

1.1K

Citations

20

H-Index

2012

Active since

Affiliations

Nova Medical (United States)(Current)

University of Calgary

Hospital Clínic de Barcelona

IRCCS Istituto Auxologico Italiano

University of Milan

Chelsea Bentow is an author at Nova Medical (United States) specializing in medicine, immunology, and autoimmune disease.

ORCID

Top concepts

Publications per year

2012–2023

30

Publications

30

Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis

Matthias Jarlborg, Delphine S. Courvoisier, Céline Lamacchia et al. · Arthritis Research & Therapy · 2020 · 110 citations · Full text

PR3-ANCA: A promising biomarker for ulcerative colitis with extensive disease

Michael Mähler, Dimitrios P. Bogdanos, Polychronis Pavlidis et al. · Clinica Chimica Acta · 2013 · 78 citations

, , +8

Prevalence of anti-DFS70 antibodies in patients with and without systemic autoimmune rheumatic diseases.

Ora Shovman, Boris Gilburd, Chen Barazani Chayat et al. · PubMed · 2018 · 78 citations

PR3-ANCA: A Promising Biomarker in Primary Sclerosing Cholangitis (PSC)

Laura M. Stinton, Chelsea Bentow, Michael Mähler et al. · PLoS ONE · 2014 · 76 citations · Full text

Comparison of Three Immunoassays for the Detection of Myositis Specific Antibodies

Michael Mähler, Zoë Betteridge, Chelsea Bentow et al. · Frontiers in Immunology · 2019 · 75 citations · Full text

Rows per page

1–5 of 30